(4S)-4-[(2S)-2-[(2S)-2-Amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-[({[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}methyl)c arbamoyl]butanoic acid

CAS : 852155-81-8

Ref. 3D-CJB15581

Informations sur le produit

• Nom: (4S)-4-[(2S)-2-[(2S)-2-Amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-[({[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}methyl)c arbamoyl]butanoic acid
• Marque: Biosynth
• Description: (4S)-4-[(2S)-2-[(2S)-2-Amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-[({[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}methyl) c arbamoyl]butanoic acid is a glp-1 analogue that may be used for the treatment of metabolic disorders. It has been shown to increase insulin production in response to glucose and also has site specific activity. The compound binds to insulin receptors, which leads to increased synthesis of intracellular insulin and activation of downstream signaling pathways. The analog has a neutral pH and is stable in biological fluids such as human serum or dogfish plasma.

Propriétés chimiques

• Masse moléculaire: 513.5 g/mol
• Formule: C₂₀H₃₁N₇O₉
• Degré de pureté: Min. 95%